Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma.
Monica Matos Correia RodriguesHenrique Manoel LedermanIona GrossmanMario Luiz V CastiglioniRenata MarchettiDaphne Centola GrassFlavio Augusto Vercillo LuisiEliana Maria Monteiro CaranPublished in: Pediatric blood & cancer (2023)
In conclusion, WB-MRI is a sensitive and specific method to detect neuroblastoma in bone and lymph nodes and highly sensible to primary tumor diagnosis, suggesting that this test is a viable alternative in places where MIBG is difficult to access. Studies with a larger number of cases are necessary for definitive conclusions.